Last Name

Paulo H Verardi PhD

TitleAssistant Professor
InstitutionUniversity of Connecticut
DepartmentPathobiology and Veterinary Science
AddressUNIT 3089
Atwater Laboratory, UNIT 3089
61 North Eagleville Road
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Hagen CJ, Titong A, Sarnoski EA, Verardi PH. Antibiotic-dependent expression of early transcription factor subunits leads to stringent control of vaccinia virus replication. Virus Res. 2014 Mar 6; 181:43-52. PMID: 24394294.
      View in: PubMed
    2. Verardi PH, Legrand FA, Chan KS, Peng Y, Jones LA, Yilma TD. IL-18 expression results in a recombinant vaccinia virus that is highly attenuated and immunogenic. J Interferon Cytokine Res. 2014 Mar; 34(3):169-78. PMID: 24168450; PMCID: PMC3942681.
    3. Holechek SA, Denzler KL, Heck MC, Schriewer J, Buller RM, Legrand FA, Verardi PH, Jones LA, Yilma T, Jacobs BL. Use of a recombinant vaccinia virus expressing interferon gamma for post-exposure protection against vaccinia and ectromelia viruses. PLoS One. 2013; 8(10):e77879. PMID: 24147092; PMCID: PMC3798613.
    4. Grigg P, Titong A, Jones LA, Yilma TD, Verardi PH. Safety mechanism assisted by the repressor of tetracycline (SMART) vaccinia virus vectors for vaccines and therapeutics. Proc Natl Acad Sci U S A. 2013 Sep 17; 110(38):15407-12. PMID: 23988330; PMCID: PMC3780884.
    5. Cervantes JL, La Vake CJ, Weinerman B, Luu S, O'Connell C, Verardi PH, Salazar JC. Human TLR8 is activated upon recognition of Borrelia burgdorferi RNA in the phagosome of human monocytes. J Leukoc Biol. 2013 Dec; 94(6):1231-41. PMID: 23906644; PMCID: PMC3828603.
    6. Verardi PH, Titong A, Hagen CJ. A vaccinia virus renaissance: new vaccine and immunotherapeutic uses after smallpox eradication. Hum Vaccin Immunother. 2012 Jul; 8(7):961-70. PMID: 22777090; PMCID: PMC3495727.
    7. Papin JF, Verardi PH, Jones LA, Monge-Navarro F, Brault AC, Holbrook MR, Worthy MN, Freiberg AN, Yilma TD. Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice. Proc Natl Acad Sci U S A. 2011 Sep 6; 108(36):14926-31. PMID: 21873194; PMCID: PMC3169153.
    8. Yilma T, Verardi P, Jones L. Development of safe and efficacious viral vaccines for animals. Crit Rev Immunol. 2010; 30(3):223-37. PMID: 20370631.
      View in: PubMed
    9. Peng Y, Lin FC, Verardi PH, Jones LA, Yilma TD. Lower levels of gamma interferon expressed by a pseudotyped single-cycle simian immunodeficiency virus enhance immunogenicity in rats. J Virol. 2009 Feb; 83(4):1592-601. PMID: 19073726; PMCID: PMC2643767.
    10. Lin FC, Peng Y, Jones LA, Verardi PH, Yilma TD. Incorporation of CD40 ligand into the envelope of pseudotyped single-cycle Simian immunodeficiency viruses enhances immunogenicity. J Virol. 2009 Feb; 83(3):1216-27. PMID: 19036823; PMCID: PMC2620918.
    11. Peng Y, Lin FC, Verardi PH, Jones LA, McChesney MB, Yilma TD. Pseudotyped single-cycle simian immunodeficiency viruses expressing gamma interferon augment T-cell priming responses in vitro. J Virol. 2007 Mar; 81(5):2187-95. PMID: 17166912; PMCID: PMC1865962.
    12. Chan KS, Verardi PH, Legrand FA, Yilma TD. Nef from pathogenic simian immunodeficiency virus is a negative factor for vaccinia virus. Proc Natl Acad Sci U S A. 2005 Jun 14; 102(24):8734-9. PMID: 15930136; PMCID: PMC1142211.
    13. Legrand FA, Verardi PH, Chan KS, Peng Y, Jones LA, Yilma TD. Vaccinia viruses with a serpin gene deletion and expressing IFN-gamma induce potent immune responses without detectable replication in vivo. Proc Natl Acad Sci U S A. 2005 Feb 22; 102(8):2940-5. PMID: 15705716; PMCID: PMC548597.
    14. Legrand FA, Verardi PH, Jones LA, Chan KS, Peng Y, Yilma TD. Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes. J Virol. 2004 Mar; 78(6):2770-9. PMID: 14990697; PMCID: PMC353749.
    15. Yilma T, Aziz F, Ahmad S, Jones L, Ngotho R, Wamwayi H, Beyene B, Yesus M, Egziabher B, Diop M, Sarr J, Verardi P. Inexpensive vaccines and rapid diagnostic kits tailor-made for the global eradication of rinderpest, and technology transfer to Africa and Asia. Dev Biol (Basel). 2003; 114:99-111. PMID: 14677681.
      View in: PubMed
    16. Verardi PH, Aziz FH, Ahmad S, Jones LA, Beyene B, Ngotho RN, Wamwayi HM, Yesus MG, Egziabher BG, Yilma TD. Long-term sterilizing immunity to rinderpest in cattle vaccinated with a recombinant vaccinia virus expressing high levels of the fusion and hemagglutinin glycoproteins. J Virol. 2002 Jan; 76(2):484-91. PMID: 11752138; PMCID: PMC136817.
    17. Verardi PH, Jones LA, Aziz FH, Ahmad S, Yilma TD. Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated In vivo without a concomitant reduction in immunogenicity. J Virol. 2001 Jan; 75(1):11-8. PMID: 11119568; PMCID: PMC113892.
    18. Jones L, Ahmad S, Chan K, Verardi P, Morton WR, Grant R, Yilma T. Enhanced safety and efficacy of live attenuated SIV vaccines by prevaccination with recombinant vaccines. J Med Primatol. 2000 Aug; 29(3-4):231-9. PMID: 11085585.
      View in: PubMed
    Verardi's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description